Editor’s note: Greetings Pandora Report subscribers! I hope you enjoyed that goofy video last week. For my first official Pandora Report, I rounded up some great stories (including a look back at history. As a social scientist, I really couldn’t help myself!)
Highlights include Botulism research and development, CDC antibiotic warning, the Nazi insect weapons program, and Marburg. Happy Friday!
Hawaii Biotech Inc. received a $5.5 million contract from the Department of Defense to continue development of drugs to treat botulinum toxin—a life threatening disease which currently has no known treatment. This grant was in addition to an existing $7.4 million grant held by Hawaii Biotech to develop anti-anthrax drugs.
Pacific Business News – “Under the contract, Hawaii Biotech will be working to improve its current anti-botulinum toxin inhibitor drug candidates that have demonstrated activity in pre-clinical testing with the goal of enhancing the stability, bioavailability and safety of these drug candidates so they can be used in humans.”
The Centers for Disease Control and Prevention released a report Tuesday criticizing the overuse of antibiotics in hospitals and the consequences of these actions. Though prescribing practices vary between hospitals and doctors, the report highlights discrepancies across patients with similar symptoms and illnesses and urges caution in use of powerful antibiotics.
The Wall Street Journal – “Overprescribing antibiotics is making many of these drugs less effective because superbugs resistant to them are developing so fast. The practice also can sicken patients, by making them vulnerable to other types of infections such as Clostridium difficile, a bacterial infection.”
In 1942, Heinrich Himmler, head of the SS, ordered the creation of an entomological institute at the Dachau concentration camp. But why? Supposedly it was to study lice, fleas, and similar pests that were causing problems for German soldiers. However, a recent report offers an additional answer.
The Guardian – “In 1944, scientists examined different types of mosquitoes for their life spans in order to establish whether they could be kept alive long enough to be transported from a breeding lab to a drop-off point. At the end of the trials, the director of the institute recommended a particular type of anopheles mosquito, a genus well-known for its capacity to transmit malaria to humans.
With Germany having signed up to the 1925 Geneva protocol, Adolf Hitler had officially ruled out the use of biological and chemical weapons during the Second World War, as had allied forces. Research into the mosquito project had to be carried out in secret.”
Exciting news, this week, regarding the development of a drug which may be able to prevent Marburg hemorrhagic fever virus from replicating in animals. The drug, BCX4430, was developed in partnership with BioCryst Pharmaceuticals Inc. through a grant from the National Institute of Allergy and Infectious Diseases (NIAID).
The Frederick News-Post – “‘The drug works by using a compound that “tricks” the virus during the RNA replication process by mimicking it,’ said Travis Warren, [a principal researcher at the U.S. Army Medical Research Institute of Infectious Diseases at Fort Detrick.] ‘Once the virus incorporates BCX4430 into its RNA, the virus is forced to end further replication. If the virus can’t effectively replicate its RNA genome, it can’t produce more infectious virus. It has no other options than to end that replication cycle.’”
(image courtesy of CDC/ James Gathany)